Payments to Third Parties definition

Payments to Third Parties. The Company may compensate Registered Representatives, Financial Advisors or other third parties for assisting the Company in marketing or selling the Contract or providing other services to the Company.

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Payments to Third Parties means any amounts paid to a Third Party (whether in the form of a royalty, up-front payment, milestone or otherwise) under a Third Party License Agreement.

Payments to Third Parties has the meaning set forth in Section 10.5.2.

Examples of Payments to Third Parties in a sentence

Payments to Third Parties We may pay compensation to ▇▇▇▇▇ ▇▇▇▇▇, however, the amount of the compensation payable to them is unascertainable.
Interest on Payments to Third Parties Unless otherwise stipulated, any amount paid by the Lender to a third party on behalf of the Borrower, that must be reimbursed by the Borrower under this Agreement, shall be calculated at the rate and in the manner set out in Section , commencing from the day of the payment.
Payments to Third Parties We may pay compensation to ▇▇▇▇▇ ▇▇▇▇▇; however, the amount of the compensation payable to them is unascertainable.
Any damages assessed to Novo Nordisk as a result of an infringement defense action and any costs, expenses, or consideration paid by or on behalf of Novo 47 Nordisk in connection with undertaking a license or settlement in order to remedy, cure, settle, or avoid such (potential) infringement pursuant to this Section 8.8 (Third Party Rights) will be deemed Third Party IP Payments to Third Parties eligible for offset by Novo Nordisk pursuant to Section 7.6.3 (Third Party Payments).
Payments to Third Parties If your account application was obtained from a third party, such as a merchant or sales agent, or if your account or the Card is co–branded with another business, we may pay compensation to them.
Payments to Third Parties must be made in accordance with the terms of their contracts; in particular, it is a violation of this policy to honor requests by Third Parties to vary the terms of contracts by: • Increasing or decreasing agreed amounts on any invoice if there is no factual, documented basis; or • Submitting multiple invoices if you suspect such invoices may be used in a manner contrary to LS&CO.

More Definitions of Payments to Third Parties

Payments to Third Parties. The Company may sponsor conferences or otherwise remunerate broker/dealers, registered representatives or other third parties for marketing or other services. PAYMENTS FROM THIRD PARTIES: The Company may enter into certain agreements under which it is reimbursed by a Portfolio's advisors, distributors and/or affiliates for the administrative or distribution services the Company provides to the Portfolio. The following Tables show the monthly income payable for each $1,000 applied under Option 1, 2, 3, or 4. Values shown are based on 3% interest for all options. ===================== =========================================== =============

Payments to Third Parties means any amounts paid to a Third Party (whether in the form of a royalty, up-front payment, milestone payment or otherwise) by or on behalf of a Party following the Effective Date in consideration for the grant of a license or other rights under a Patent or other intellectual property rights controlled by such Third Party that are [*] to Develop, Manufacture, or Commercialize the Product under (i) a Third Party License Agreement for one or more Major Markets entered into by a Party in accordance with this Agreement, (ii) the [*] Agreement dated [*] between [*] and [*], as amended (the “[*] Agreement”), or (iii) the [*] Agreement. 1.91 “Payors” means, pharmacy benefit managers, managed health care organizations, group purchasing organizations, large employers, government agencies and government health care programs (e.g., the U.S. Department of Veterans Affairs and Medicare in any form), and similar programs or organizations. 1.92 “Person” means any individual, firm, corporation, partnership, limited liability company, trust, business trust, joint venture, Governmental Authority, association, or other entity. 1.93 “Post-Market Surveillance” means a program in place after the receipt of Regulatory Approval to be further defined in a pharmacovigilance agreement entered into pursuant to Section 8.2 that provides for (a) monitoring the safety of a product in the market, including reporting of certain Adverse Events to Regulatory Authorities; (b) monitoring, investigating, reporting, and responding to complaints from the market, whether medical, technical, or otherwise; and (c) evaluating whether additional actions, such as a label amendment, dear doctor letter, or recall, may be necessary. 1.94 “Primary Position Detail” means, with respect to the Product, a Detail (a) in which key attributes of the Product are orally presented consistent with the terms of this Agreement and

Payments to Third Parties has the meaning set forth in Section 10.5.2. “Phase I Clinical Trial” means the first administration of a candidate drug in a human clinical trial in any country that would satisfy the requirements of 21 CFR 312.21(a). “Phase II Clinical Trial” means a controlled dose human clinical trial prospectively designed to evaluate the efficacy and safety of a candidate drug in the targeted patient population and to define the optimal dosing regimen in any country that would satisfy the requirements of 21 CFR 312.21(b). “Phase III Clinical Trial” means a controlled, and usually multi-center, human clinical trial, involving patients with the disease or condition of interest to obtain sufficient efficacy and safety data to support Regulatory Approval of a candidate drug that would satisfy the requirements of 21 CFR 312.21(c). -14-